Literature DB >> 30684477

Risk of Ischemic Mitral Regurgitation Recurrence After Combined Valvular and Subvalvular Repair.

Francesco Nappi1, Mario Lusini2, Sanjeet Singh Avtaar Singh3, Orlando Santana4, Massimo Chello2, Christos G Mihos4.   

Abstract

BACKGROUND: Mitral valve repair (MVr) combined with papillary muscle approximation (PMA) may improve repair durability in severe ischemic mitral regurgitation (MR), when compared with MVr alone. We sought to identify preoperative transthoracic echocardiographic markers associated with MR recurrence after MVr with PMA.
METHODS: A post-hoc analysis was performed on patients with severe ischemic MR who underwent coronary artery bypass graft surgery with MVr with PMA in the papillary muscle approximation randomized trial. The PMA was performed utilizing a 4-mm polytetrafluoroethylene graft placed around the papillary muscles. Linear regression analyses and receiver-operating characteristic curves were used to identify echocardiographic variables and diagnostic models associated with recurrent MR.
RESULTS: There were 48 patients with a mean age of 63 ± 7 years, a left ventricular ejection fraction of 35% ± 5%, and a left ventricular end-diastolic diameter of 63 ± 3 mm. Of these, 37 patients had baseline and 5-year follow-up echocardiograms, with moderate-to-severe MR recurring in 27%. Linear regression analyses revealed associations between preoperative pulmonary artery systolic pressure (standardized beta coefficient, β = 0.49/mm Hg, p = 0.002), MV tenting area (β = 0.47/cm2, p = 0.004), a symmetric MV tethering pattern (β = 0.44, p = 0.007), and left ventricular end-diastolic diameter (β = 0.37/mm, p = 0.02) with follow-up MR grade. The presence of both MV tenting area 3.1 cm2 or greater (area under the curve 0.822) and left ventricular end-diastolic diameter of 64 mm or greater (area under the curve 0.801) was the most robust discriminative model for moderate-to-severe MR recurrence (specificity 92%, sensitivity 69%, area under the curve 0.804, p = 0.003).
CONCLUSIONS: In patients undergoing coronary artery bypass graft surgery with MVr plus PMA, the extent of baseline MV apparatus and left ventricle geometric remodeling identifies patients at increased risk for MR recurrence.
Copyright © 2019 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30684477     DOI: 10.1016/j.athoracsur.2018.12.030

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  15 in total

Review 1.  The Choice of Treatment in Ischemic Mitral Regurgitation With Reduced Left Ventricular Function.

Authors:  Francesco Nappi; Sanjeet Singh Avtaar Singh; Muralidhar Padala; David Attias; Mohammed Nejjari; Christos G Mihos; Umberto Benedetto; Robert Michler
Journal:  Ann Thorac Surg       Date:  2019-08-22       Impact factor: 4.330

2.  Moderate to severe ischemic mitral regurgitation: More data to guide the choice. Why not consider the use of subvalvular repair?

Authors:  Antonio Nenna; Massimo Chello; Francesco Nappi
Journal:  Cardiol J       Date:  2020       Impact factor: 2.737

3.  Translocation of the Mitral Valve in an Acute Large Animal Model.

Authors:  Chetan Pasrija; Rachael Quinn; Erik Strauss; Libin Wang; Douglas Tran; Michael N D'Ambra; James S Gammie
Journal:  J Cardiovasc Transl Res       Date:  2022-02-17       Impact factor: 4.132

4.  Ischemic functional mitral regurgitation: from pathophysiological concepts to current treatment options. A systemic review for optimal strategy.

Authors:  Francesco Nappi; Antonio Nenna; Christos Mihos; Cristiano Spadaccio; Federico Gentile; Massimo Chello; Yoshiro Matzui
Journal:  Gen Thorac Cardiovasc Surg       Date:  2021-01-05

Review 5.  The Use of Radial Artery for CABG: An Update.

Authors:  Francesco Nappi; Francesca Bellomo; Pierluigi Nappi; Camilla Chello; Adelaide Iervolino; Massimo Chello; Christophe Acar
Journal:  Biomed Res Int       Date:  2021-04-07       Impact factor: 3.411

Review 6.  Mitral regurgitation after transcatheter aortic valve replacement.

Authors:  Francesco Nappi; Antonio Nenna; Irina Timofeeva; Christos Mihos; Federico Gentile; Massimo Chello
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

7.  Predicting clinical outcome by indexed mitral valve tenting in functional mitral valve regurgitation.

Authors:  Maria von Stumm; Florian Dudde; Theresa Holst; Tatjana Sequeira-Gross; Jonas Pausch; Lisa Müller; Christoph R Sinning; Hermann Reichenspurner; E Girdauskas
Journal:  Open Heart       Date:  2021-01

8.  Exploring the Operative Strategy for Secondary Mitral Regurgitation: A Systematic Review.

Authors:  Francesco Nappi; Sanjeet Singh Avtaar Singh; Francesca Bellomo; Pierluigi Nappi; Camilla Chello; Adelaide Iervolino; Massimo Chello
Journal:  Biomed Res Int       Date:  2021-06-22       Impact factor: 3.411

Review 9.  Mitral regurgitation: lessons learned from COAPT and MITRA-Fr.

Authors:  Francesco Nappi; Antonio Nenna; Sanjeet Singh Avvtar Sing; Irina Timofeeva; Christos Mihos; Federico Gentile; Massimo Chello
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

10.  The Use of Subvalvular Repair for Functional Mitral Regurgitation.

Authors:  Francesco Nappi
Journal:  Ann Thorac Cardiovasc Surg       Date:  2020-10-02       Impact factor: 1.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.